Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay S Patel

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2022
Clinical Safety Experience of TAK-003 for Dengue Fever: A New Tetravalent Live Attenuated Vaccine CandidateSanjay S Patel, Martina Rauscher, Maria Kudela, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 4, 2019
MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complicationsSanjay S Patel, Svetlana Bizjajeva, Esther Heijnen, et al.
American Journal of Hematology|April 19, 2023
Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapyJorge Monge, Meri Razavi, Liming Bao, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 17, 2019
Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young childrenSanjay S Patel, Svetlana Bizjajeva, Kelly Lindert, et al.
Acta Pharmaceutica (Zagreb, Croatia)|January 22, 2013
Current status and future prospects of drug eluting stents for restenosisMaulik J Patel, Sanjay S Patel, Nidhi S Patel, et al.
Thyroid Research|October 21, 2017
Hyalinizing trabecular tumor of the thyroid gland and its significant diagnostic issueDustin J Jones, Christopher R Kieliszak, Sanjay S Patel, et al.
Blood Advances|June 8, 2021
Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AMLDamodaran Narayanan, Olga Pozdnyakova, Robert P Hasserjian, et al.
Expert Review of Vaccines|March 18, 2025
Pregnancy outcomes following unintentional exposure to TAK-003, a live-attenuated tetravalent dengue vaccineMartina Rauscher, Zeb Youard, Alice Faccin, et al.
Leukemia & Lymphoma|February 5, 2024
Subcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administrationCynthia M Magro, Taylor Kalomeris, Christina R Shreve, et al.
Human Vaccines & Immunotherapeutics|October 17, 2023
An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-lifeSanjay S Patel, Peter Winkle, Alice Faccin, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2022
Clinical Safety Experience of TAK-003 for Dengue Fever: A New Tetravalent Live Attenuated Vaccine CandidateSanjay S Patel, Martina Rauscher, Maria Kudela, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 4, 2019
MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complicationsSanjay S Patel, Svetlana Bizjajeva, Esther Heijnen, et al.
American Journal of Hematology|April 19, 2023
Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapyJorge Monge, Meri Razavi, Liming Bao, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 17, 2019
Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young childrenSanjay S Patel, Svetlana Bizjajeva, Kelly Lindert, et al.
Acta Pharmaceutica (Zagreb, Croatia)|January 22, 2013
Current status and future prospects of drug eluting stents for restenosisMaulik J Patel, Sanjay S Patel, Nidhi S Patel, et al.
Thyroid Research|October 21, 2017
Hyalinizing trabecular tumor of the thyroid gland and its significant diagnostic issueDustin J Jones, Christopher R Kieliszak, Sanjay S Patel, et al.
Blood Advances|June 8, 2021
Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AMLDamodaran Narayanan, Olga Pozdnyakova, Robert P Hasserjian, et al.
Expert Review of Vaccines|March 18, 2025
Pregnancy outcomes following unintentional exposure to TAK-003, a live-attenuated tetravalent dengue vaccineMartina Rauscher, Zeb Youard, Alice Faccin, et al.
Leukemia & Lymphoma|February 5, 2024
Subcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administrationCynthia M Magro, Taylor Kalomeris, Christina R Shreve, et al.
Human Vaccines & Immunotherapeutics|October 17, 2023
An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-lifeSanjay S Patel, Peter Winkle, Alice Faccin, et al.
Pageof 5